NanoCarrier Co. Ltd
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastom… Read more
NanoCarrier Co. Ltd (3NQ) - Net Assets
Latest net assets as of September 2025: €2.63 Billion EUR
Based on the latest financial reports, NanoCarrier Co. Ltd (3NQ) has net assets worth €2.63 Billion EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€3.38 Billion) and total liabilities (€742.99 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.63 Billion |
| % of Total Assets | 78.0% |
| Annual Growth Rate | -13.55% |
| 5-Year Change | -63.47% |
| 10-Year Change | -77.41% |
| Growth Volatility | 26.5 |
NanoCarrier Co. Ltd - Net Assets Trend (2014–2025)
This chart illustrates how NanoCarrier Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NanoCarrier Co. Ltd (2014–2025)
The table below shows the annual net assets of NanoCarrier Co. Ltd from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €2.74 Billion | -19.92% |
| 2024-03-31 | €3.42 Billion | -19.56% |
| 2023-03-31 | €4.25 Billion | -23.59% |
| 2022-03-31 | €5.57 Billion | -25.77% |
| 2021-03-31 | €7.50 Billion | -14.47% |
| 2020-03-31 | €8.77 Billion | +49.14% |
| 2019-03-31 | €5.88 Billion | +26.13% |
| 2018-03-31 | €4.66 Billion | -53.69% |
| 2017-03-31 | €10.07 Billion | -16.98% |
| 2016-03-31 | €12.13 Billion | -16.37% |
| 2015-03-31 | €14.50 Billion | +6.66% |
| 2014-03-31 | €13.60 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to NanoCarrier Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 391711300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €5.73 Billion | 209.02% |
| Total Equity | €2.74 Billion | 100.00% |
NanoCarrier Co. Ltd Competitors by Market Cap
The table below lists competitors of NanoCarrier Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yuen Chang Stainless Steel Co Ltd
TW:2069
|
$58.74 Million |
|
CO2 Energy Transition Corp. Unit
NASDAQ:NOEMU
|
$58.79 Million |
|
J Resources Asia Pasifik Tbk
JK:PSAB
|
$58.79 Million |
|
YTO Express (International) Holdings Limited
PINK:YTOEF
|
$58.83 Million |
|
Consórcio Alfa de Administração S.A
SA:BRGE3
|
$58.72 Million |
|
Nucleus Software Exports Limited
NSE:NUCLEUS
|
$58.71 Million |
|
UY Scuti Acquisition Corp.
NASDAQ:UYSC
|
$58.70 Million |
|
Cat Loi JSC
VN:CLC
|
$58.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NanoCarrier Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,421,388,000 to 2,739,831,000, a change of -681,557,000 (-19.9%).
- Net loss of 835,380,000 reduced equity.
- Other factors increased equity by 153,823,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-835.38 Million | -30.49% |
| Other Changes | €153.82 Million | +5.61% |
| Total Change | €- | -19.92% |
Book Value vs Market Value Analysis
This analysis compares NanoCarrier Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €233.15 | €0.88 | x |
| 2018-03-31 | €107.82 | €0.88 | x |
| 2019-03-31 | €119.01 | €0.88 | x |
| 2020-03-31 | €132.75 | €0.88 | x |
| 2021-03-31 | €107.33 | €0.88 | x |
| 2022-03-31 | €79.52 | €0.88 | x |
| 2023-03-31 | €60.64 | €0.88 | x |
| 2024-03-31 | €48.61 | €0.88 | x |
| 2025-03-31 | €38.81 | €0.88 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NanoCarrier Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -30.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -769.82%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 1.46x
- Recent ROE (-30.49%) is above the historical average (-31.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -8.19% | -235.81% | 0.03x | 1.05x | €-2.47 Billion |
| 2015 | -1.43% | -30.67% | 0.05x | 1.01x | €-1.66 Billion |
| 2016 | -20.92% | -1044.03% | 0.02x | 1.27x | €-3.75 Billion |
| 2017 | -26.58% | -1223.65% | 0.02x | 1.29x | €-3.68 Billion |
| 2018 | -116.20% | -2090.65% | 0.03x | 1.64x | €-5.88 Billion |
| 2019 | -30.76% | -364.08% | 0.06x | 1.46x | €-2.40 Billion |
| 2020 | -22.92% | -363.43% | 0.06x | 1.02x | €-2.89 Billion |
| 2021 | -37.81% | -905.24% | 0.04x | 1.04x | €-3.59 Billion |
| 2022 | -33.80% | -712.67% | 0.04x | 1.28x | €-2.44 Billion |
| 2023 | -30.82% | -648.39% | 0.03x | 1.36x | €-1.74 Billion |
| 2024 | -22.80% | -575.61% | 0.03x | 1.48x | €-1.12 Billion |
| 2025 | -30.49% | -769.82% | 0.03x | 1.46x | €-1.11 Billion |
Industry Comparison
This section compares NanoCarrier Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NanoCarrier Co. Ltd (3NQ) | €2.63 Billion | -8.19% | 0.28x | $58.74 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |